In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications

BACKGROUND: Stent angioplasty provides a minimally invasive treatment for atherosclerotic vessels. However, no treatment option for atherosclerosis-associated endothelial dysfunction, which is accompanied by a loss of CD39, is available, and hence, adverse effects like thromboembolism and restenosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Abraham, Meike-Kristin, Nolte, Andrea, Reus, Rebekka, Behring, Andreas, Zengerle, Diane, Avci-Adali, Meltem, Hohmann, Jan David, Peter, Karlheinz, Schlensak, Christian, Wendel, Hans Peter, Krajewski, Stefanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575070/
https://www.ncbi.nlm.nih.gov/pubmed/26381750
http://dx.doi.org/10.1371/journal.pone.0138375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575070/
https://www.ncbi.nlm.nih.gov/pubmed/26381750
http://dx.doi.org/10.1371/journal.pone.0138375

Ejemplares similares